IP Library Granted Patent US 10,264,793
Granted Patent B2
US 10,264,793 · App. 15/529,265 · Granted Apr 23, 2019

Antimicrobial copper compositions and their use in treatment of foodstuffs and surfaces

Inventors: John Meccia (Ringoes, NJ); Ronald C. Shapira (New York, NY); Francis Dautreuil (Seabrook, TX); James Dietrich (Harrisburg, PA)
Assignee: CMS TECHNOLOGY, INC.
A01N59/20A23B4/20A23B5/14A23B7/154A23B9/26A23L3/358A23L3/3508A23V2002/00Y02A40/943
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,264,793
App. No.
15/529,265
Granted
Apr 23, 2019
Kind
B2
Abstract

The present disclosure provides compositions for antimicrobial use comprising a mineral acid, an organic acid, or a combination thereof; a copper(II) salt; and a buffering salt, a detergent, or a combination thereof. The present disclosure also provides methods for reducing the number of pathogens on a surface by applying compositions of the present disclosure to the surface.

Claims (22)

1. A composition comprising:

a mineral acid buffered with a conjugate salt;

a copper(II) salt, wherein the copper(II) salt concentration is between about 35 ppm and about 100 ppm; and

between 0.01 and 0.3 weight percent of an alkyl polyglycoside, based on the weight of the composition;

wherein the composition is an aqueous solution with a pH between 1 and 4.

2. The composition of claim 1 , wherein the copper(II) salt is copper (II) sulfate.

3. The composition of claim 1 , wherein the mineral acid is sulfuric acid, phosphoric acid, hydrochloric acid, or a combination thereof.

4. The composition of claim 1 , further comprising a buffering salt wherein the buffering salt is ammonium sulfate, sodium sulfate, sodium chloride, calcium sulfate, or a combination thereof.

5. The composition of claim 4 , wherein the buffering salt concentration is between 0.05 and 0.5 weight percent, based on the weight of the composition.

6. The composition of claim 1 , further comprising an antioxidant.

7. The composition of claim 6 , wherein the antioxidant concentration is between 0.01 and 1 weight percent or between 0.01 and 0.05 weight percent, based on the weight of the composition.

8. The composition of claim 1 , wherein the ratio of water to the remaining composition components is between about 1:1 and about 500:1 or between about 50:1 and about 500:1.

9. The composition of claim 1 , wherein the composition is in the form of a solid that is a pellet, granule, powder, pod, or tablet, optionally encased in a water-soluble film or packaging, wherein the water-soluble film or packaging is a polyvinyl alcohol film, an aliphatic polyether film, or a polyethylene glycol film.

10. The composition of claim 1 , wherein the pH of the aqueous solution is between 1.6 and 3.5.

11. The composition of claim 1 , comprising between 0.01 and 0.25 weight percent of the alkyl polyglycoside, based on the weight of the composition.

12. A method of reducing the number of pathogens on a surface comprising applying the composition of claim 1 to the surface, wherein the surface is a foodstuff surface selected from the group consisting of a fruit, a vegetable, an algae, a seed, a grain, a sprout, a legume, soy, a nut, a meat product including a beef product and a pork product, a poultry product, a seafood product, or a dairy product.

13. The method of claim 12 , wherein the pathogen is a bacterium that is optionally Salmonella enterica, Listeria monocytogenes, Escherichia coli, Clostridium botulinum, Clostridium difficile, Campylobacter, Bacillus cereus, Vibrio parahaemolyticus, Vibrio cholerae, Vibrio vulnificus, Staphylococcus aureus, Yersinia enterocolitica, shigella , or a combination thereof; a virus that is optionally enterovirus, norovirus, influenza, rotavirus, or a combination thereof; or a parasite that is optionally Cryptosporidium, Toxoplasma gondii, Giardia duodenalis, Cyclospora cayetanensis, Trichinella spiralis, Taenia saginata, Taenia solium , or a combination thereof.

14. The method of claim 12 , wherein the composition is an aqueous solution at a temperature between about 32° F. and about 212° F. or between about 32° F. and about 135° F.

15. The method of claim 14 , wherein the applying comprises a submersion time between about 2 seconds and about 180 seconds, between about 2 seconds and about 120 seconds, between about 2 seconds and about 90 seconds, between about 2 seconds and about 60 seconds, or between about 2 seconds and about 30 seconds.

16. The method of claim 12 , wherein the applying comprises sprinkling, spraying, rinsing, soaking, immersing, or washing.

17. A method of reducing the number of pathogens in a volume of a liquid food product comprising adding the composition of claim 1 to the volume of the liquid food product.

18. The method of claim 17 , wherein the pathogen is a bacterium that is optionally Salmonella enterica, Listeria monocytogenes, Escherichia coli, Clostridium botulinum, Clostridium difficile, Campylobacter, Bacillus cereus, Vibrio parahaemolyticus, Vibrio cholerae, Vibrio vulnificus, Staphylococcus aureus, Yersinia enterocolitica, shigella , or a combination thereof; a virus that is optionally enterovirus, norovirus, influenza, rotavirus, or a combination thereof; or a parasite that is optionally Cryptosporidium, Toxoplasma gondii, Giardia duodenalis, Cyclospora cayetanensis, Trichinella spiralis, Taenia saginata, Taenia solium , or a combination thereof.

Assignments (4)
CORRECTIVE ASSIGNMENT TO CORRECT THE ADDRESS OF THE ASSIGNEE PREVIOUSLY RECORDED AT REEL: 66924 FRAME: 968. ASSIGNOR(S) HEREBY CONFIRMS THE CHANGE OF NAME. Recorded Apr 2, 2024
From: CMS TECHNOLOGY, INC.
To: CMS TECHNOLOGY, LLC
Reel/Frame 066986/0172 →
CHANGE OF NAME Recorded Feb 26, 2024
From: CMS TECHNOLOGY, INC.
To: CMS TECHNOLOGY, LLC
Reel/Frame 066924/0968 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 25, 2024
From: CMS TECHNOLOGY, INC.
To: CMS TECHNOLOGY, LLC
Reel/Frame 066369/0022 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 24, 2017
From: MECCIA, JOHN; SHAPIRA, RON; DAUTREUIL, FRANCIS; DIETRICH, JAMES
To: CMS TECHNOLOGY, INC.
Reel/Frame 042492/0219 →
Continuity (2)
Provisional Application 62084278 · Nov 25, 2014
Related Publication 20170258093A1 · Sep 14, 2017
Cited By (2)
US 12,221,354 US 12,421,665